Nordahl T E, Stein M B, Benkelfat C, Semple W E, Andreason P, Zametkin A, Uhde T W, Cohen R M
Department of Psychiatry, UC Davis Medical Center, Sacramento, California, USA.
Biol Psychiatry. 1998 Nov 15;44(10):998-1006. doi: 10.1016/s0006-3223(98)00026-2.
Abnormal left/right (L/R) hemispheric ratios of regional cerebral glucose metabolic rates (rCMRglc) (hippocampus and inferior prefrontal cortex) have been noted in unmedicated panic disorder patients.
An independent group of panic disorder patients placed on imipramine was studied with positron-emission tomography, testing for evidence of normalization versus persistence of the abnormal rCMRglc ratios. Differences in orbital frontal rCMRglc values between the imipramine-treated and the previously reported unmedicated panic disorder patients were tested examining for evidence that the differences would resemble those noted in obsessive-compulsive disorder (OCD) patients treated with clomipramine.
We found the same abnormally low L/R hippocampal and posterior inferior prefrontal rCMRglc ratios in the imipramine-treated panic disorder patients. In addition, we found posterior orbital frontal rCMRglc decreases in the imipramine-treated panic disorder patients compared with the unmedicated panic disorder patients.
These abnormal asymmetries found in unmedicated panic disorder patients and now in imipramine-treated panic disorder patients may reflect a trait abnormality. The orbital frontal rCMRglc differences between the imipramine-treated and unmedicated patients are similar to changes noted in OCD patients treated with clomipramine and may reflect direct or indirect effects of imipramine treatment in panic disorder patients.
未用药的惊恐障碍患者已被发现区域脑葡萄糖代谢率(rCMRglc)(海马体和前额叶下部皮质)的左右半球比率异常。
对一组服用丙咪嗪的惊恐障碍患者进行独立研究,采用正电子发射断层扫描,检测异常rCMRglc比率正常化或持续存在的证据。测试丙咪嗪治疗组与先前报道的未用药惊恐障碍患者之间眶额部rCMRglc值的差异,以检查是否有证据表明这些差异与用氯米帕明治疗的强迫症(OCD)患者中所观察到的差异相似。
我们发现在服用丙咪嗪的惊恐障碍患者中,海马体和后下前额叶rCMRglc的左右比率同样异常低。此外,我们发现与未用药的惊恐障碍患者相比,服用丙咪嗪的惊恐障碍患者眶额后部rCMRglc降低。
在未用药的惊恐障碍患者以及现在服用丙咪嗪的惊恐障碍患者中发现的这些异常不对称可能反映了一种特质异常。服用丙咪嗪的患者与未用药患者之间眶额部rCMRglc的差异类似于用氯米帕明治疗的OCD患者中所观察到的变化,可能反映了丙咪嗪治疗对惊恐障碍患者的直接或间接影响。